|
"feng yh"的相關文件
顯示項目 1-7 / 7 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-10 |
Exploring neuron-specific steroid synthesis and DHEAS therapy in Alzheimer's disease
|
Lin, HY;Feng, YH;Kao, TJ;Chen, HC;Chen, GY;Ko, CY;Hsu, TI |
| 國家衛生研究院 |
2024-03 |
Mitochondrial mechanisms in temozolomide resistance: Un-raveling the complex interplay and therapeutic strategies in glioblastoma
|
Li, HY;Feng, YH;Lin, CL;Hsu, TI |
| 國家衛生研究院 |
2023-11-07 |
Correlation of insulin-like growth factor 1 with cognitive functions in mild traumatic brain injury patients
|
Ou, JC;Feng, YH;Chen, KY;Chiang, YH;Hsu, TI;Wu, CC |
| 國家衛生研究院 |
2022-05 |
Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression
|
Feng, YH;Lim, SW;Lin, HY;Wang, SA;Hsu, SP;Kao, TJ;Ko, CY;Hsu, TI |
| 國家衛生研究院 |
2021-07-07 |
The effectiveness and safety of immune checkpoint inhibitors in non-small cell lung cancer patients with stage III/IV: A multicenter study
|
Hsu, JC;Nguyen, PA;Chen, YT;Yang, SC;Lin, CC;Yang, YH;Lin, YC;Hsia, TC;Hsieh, HC;Wu, JS;Chang, CP;Feng, YH;Lin, PC;Hsu, PC;Tzeng, HE;Chien, SC;Chang, WC;Chang, CC;Yang, HC;Lee, CM;Lu, CY |
| 國家衛生研究院 |
2018-04-05 |
ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2016-05 |
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT |
顯示項目 1-7 / 7 (共1頁)
1
每頁顯示[10|25|50]項目
|
